Work

069 High baseline serum IL-6 identifies a subgroup of rheumatoid arthritis patients with rapid joint damage and clinical progression and predicts increased sarilumab treatment response

Year: 2019

Type: article

Source: Lara D. Veeken

DOI: 10.1093/rheumatology/kez106.068

Authors: Anita Boyapati, Jérôme Msihid, Sergio Schwartzman, Ernest Choy, Gerd R Burmester, Gordon Lam, Toshio Kimura, Jonathan Sadeh, Neil M H Graham

Institutions: Regeneron (United States), Sanofi (France), Hospital for Special Surgery, Cardiff University, Charité – Universitätsmedizin Berlin, Sanofi (United States)

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2938059526

FWCI: 1.331

Cites:

Cited by: 7

Related to: 10